CONDENSED BALANCE SHEETS - USD ($)		Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash		$ 916,228	$ 0
Prepaid expenses		664,163	0
Deferred offering costs		0	523,475
Total current assets		1,580,391	523,475
Investments held in Trust Account		1,000,165,167	0
Total assets		1,001,745,558	523,475
Current liabilities
Accrued expenses		922,945	364,935
Promissory note - related party		0	147,385
Total current liabilities		922,945	512,320
Warrant liabilities	[1]	30,198,979	0
Deferred underwriting commissions		35,000,000	0
Total liabilities		66,121,924	512,320
Commitments and contingencies
Shareholders’ equity (deficit)
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding		0	0
Additional paid-in capital		0	22,500
Accumulated deficit		(64,378,866)	(13,845)
Total shareholders’ equity (deficit)		(64,376,366)	11,155	[2]
Total liabilities and shareholders’ equity (deficit)		1,001,745,558	523,475
Class A Ordinary Shares Subject To Redemotion
Current liabilities
Class A ordinary shares, $0.0001 par value; 100,000,000 and 0 shares subject to possible redemption at $10.00 per share at September 30, 2021 and December 31, 2020, respectively		1,000,000,000	0
Class A Ordinary Shares
Shareholders’ equity (deficit)
Common stock		0	0
Class B Ordinary Shares
Shareholders’ equity (deficit)
Common stock		$ 2,500	$ 2,500

[1] On February 4, 2021, the Company consummated the sale of Over-Allotment Units pursuant to the underwriters’ partial exercise of their over-allotment option. Share amounts as of December 31, 2020 have been retroactively restated to account for the share recapitalization events as discussed in Note 5.

[2] On February 4, 2021, the Company consummated the sale of Over-Allotment Units pursuant to the underwriters’ partial exercise of their over-allotment option. Share amounts as of September 30, 2020 and December 31, 2020 have been retroactively restated to account for the share recapitalization events as discussed in Note 5.